On the afternoon of February 24th, a delegation from Shenzhen Cell Valley, led by Chairman Shi Yuanyuan, Chief Scientist Wang Jianxun, Deputy General Manager Tang Xiaotong, Head of Business Department Tang Hui, Precision Medicine Expert Jia Haitao, Assistant to the Chairman Fu Yuchen, and Head of Marketing Sun Rui, visited Pingshan District Central Hospital for an exchange visit. They were warmly received by hospital leaders including President Yang Yifeng, Vice President Li Jin, and Vice President Xia Liangwei, along with directors of various departments. A symposium was held at the hospital's conference center.

At the beginning of the meeting, Vice President Xia Liangwei of Pingshan District Central Hospital provided a detailed introduction to the hospital's overall situation. The hospital is large-scale, equipped with advanced medical facilities, and offers a comfortable environment for patients. It features a comprehensive range of departments covering multiple key specialties, providing all-around medical services. President Yang Yifeng stated that in terms of medical technology, the hospital has introduced numerous academic leaders and renowned clinical experts from Xiangya School of Medicine. Through close cooperation with the Second Xiangya Hospital, and by implementing the "three res" of high-end medical brands, technologies, and personnel, the hospital has achieved its goals of supplementing medical service shortcomings, strengthening grassroots capabilities, building a highland, and highlighting characteristics in Pingshan District.

Professor Shi Yuanyuan, Chairman of Shenzhen Cell Valley, introduced the company's progress in the field of cell therapy. Shenzhen Cell Valley has achieved significant breakthroughs in core cell therapy technologies, covering preliminary preparation, quality control processes, and clinical applications. The company boasts abundant R&D achievements, with multiple projects at the forefront of the industry and outstanding clinical application cases that have successfully helped numerous patients alleviate their conditions and improve their quality of life. The purpose of this return visit is to further deepen cooperation, accelerate the implementation and promotion of cell therapy technology in clinical applications by integrating the advantages of both the hospital and the enterprise.

Subsequently, both sides engaged in in-depth discussions regarding the development of universal cell therapy products and their application for recurrent and refractory diseases. During the two-hour symposium, renowned experts from across the country—including Sun Junzhong (Director of Oncology), Wang Qunwei (Director of General Surgery), Liu Xintong (Director of Neurology), Li Xiang (Director of Urology), Liu Minghui (Director of Medical Imaging), Yan Chunhua (Director of General Practice and Geriatrics), Li Chaoyang (Director of Sleep Center), and Tan Zhiping (Director of Central Laboratory)—conducted pragmatic and productive discussions with the Cell Valley team. Chairman Shi Yuanyuan expressed that he was deeply impressed by the fact that this brand-new hospital houses so many national-level clinical experts, and felt fortunate to be located only one kilometer away. Under the leadership of President Yang and these medical giants, Pingshan District Central Hospital is sure to soon become a medical highland in eastern Shenzhen. Shenzhen Cell Valley will rely on its technical accumulation and innovation capabilities in cell therapy to provide full-chain support from R&D to application for the hospital. By linking the hospital's clinical practice platform and professional medical team, both sides will work together to assist in the construction of a regional cell therapy demonstration center.

After the meeting, the Shenzhen Cell Valley team, accompanied by President Yang Yifeng and others, toured key departments and facilities including the outpatient lobby, inpatient building, and central laboratory, gaining further insight into the hospital's comprehensive strength. Through exchanges and visits, both parties reached a cooperation intention to promote the cell therapy industry and clinical applications in Pingshan. In the future, both sides will cooperate closely to accelerate the clinical translation of cell therapy technology, provide patients with higher quality medical services, and promote the high-quality development of the cell therapy industry.